Literature DB >> 23330877

Ectopic extramedullary hematopoiesis: evaluation and treatment of a rare and benign paraspinal/epidural tumor.

Tobias A Mattei1, Michael Higgins, Flynn Joseph, Ehud Mendel.   

Abstract

Ectopic extramedullary hematopoiesis (EMH), defined as the formation of blood cells outside the bone marrow, usually occurs in a scenario of chronic anemia when, even after conversion of the bony yellow marrow to red marrow, the body is still unable to meet the demand for red blood cells. Ectopic extramedullary hematopoiesis most commonly occurs in the liver and spleen but may, in fact, occur almost anywhere in the body. Although previous reports have documented EMH presenting as paraspinal masses, such lesions have almost always been associated with a predisposing hematological disorder such as hemolytic anemia, myelofibrosis or myelodysplastic syndromes, thalassemia, polycythemia vera, leukemia, or lymphoma. The authors of this report describe the first reported instance of EMH in a patient presenting with a symptomatic epidural and paraspinal cervical lesion arising from the posterior spinal elements and no known predisposing hematological disease. Initial radiographs revealed a bony lesion arising posteriorly from the C2-3 laminae and spinous processes. Subsequent imaging suggested the diagnosis, which was confirmed by CT-guided biopsy, peripheral blood smears, and bone marrow aspirate. Despite epidural compression and slight displacement of the cervical cord and thecal sac, the patient's symptoms were limited to pain and diminished cervical range of motion. Therefore, surgery was deferred in favor of nonsurgical therapy. Several alternative modalities for the treatment of EMH have been suggested in the literature, including cytotoxic agents and radiotherapy. The authors opted for an approach utilizing directed low-dose radiotherapy of a total of 25 Gy divided in 2.5-Gy fractions. At the 3-month follow-up, the patient continued to be asymptomatic, and MRI demonstrated a significant reduction in the dimensions of the lesion. Extramedullary hematopoiesis with spinal cord compression in the absence of a preexisting hematological disorder has not been described in the context of clinical neurosurgical practice. Recognizing that EMH may present as an epidural or paraspinal lesion is important since chemotherapy and radiotherapy are effective therapeutic options in the majority of patients who suffer few if any symptoms. Extensive evaluation for underlying hematological disorders is necessary before undertaking directed therapy. Inadvertent resection of these highly vascularized masses may risk catastrophic intraoperative hemorrhage with no proven benefit as compared with medical treatment, which usually provides excellent long-term outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23330877     DOI: 10.3171/2012.12.SPINE12720

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  4 in total

1.  Long segment spinal epidural extramedullary hematopoiesis.

Authors:  Kanwaljeet Garg; Pankaj Kumar Singh; Manmohan Singh; P Sarat Chandra; Bhawani Shankar Sharma
Journal:  Surg Neurol Int       Date:  2013-12-26

2.  Myelopathy due to Spinal Extramedullary Hematopoiesis in a Patient with Polycythemia Vera.

Authors:  Shuhei Ito; Nobuyuki Fujita; Naobumi Hosogane; Narihito Nagoshi; Mitsuru Yagi; Akio Iwanami; Kota Watanabe; Takashi Tsuji; Masaya Nakamura; Morio Matsumoto; Ken Ishii
Journal:  Case Rep Orthop       Date:  2017-01-04

3.  Spinal Cord Compression Secondary to Extramedullary Hematopoiesis: Case Report and Review of the Literature.

Authors:  Arthur Wang; Nathan Carberry; Elena Solli; John Gillick; Humayun Islam; Virany Hillard
Journal:  Case Rep Oncol       Date:  2016-05-31

4.  A Case of Multifocal Extramedullary and Non-Hepatosplenic Extramedullary Hematopoiesis in a 43-Year-Old Man with a History of Congenital Eisenmenger Syndrome.

Authors:  Krzysztof Gawroński; Kamila Kruczkowska-Tarantowicz; Piotr Rzepecki; Daniel Lisicki
Journal:  Am J Case Rep       Date:  2022-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.